SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5x59'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UYU_A_CAMA1416_0 (CYTOCHROME P450-CAM)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	PHE A1012 THR A 791 VAL A1128 VAL A1022	None	1.19A	1uyuA-5x59A: undetectable	1uyuA-5x59A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRK_A_TFPA204_1 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 9	PHE A 116 LEU A 284 PHE A 112 PHE A 183 LEU A 265	None	1.26A	1wrkA-5x59A: undetectable 1wrkB-5x59A: undetectable	1wrkA-5x59A: 4.74 1wrkB-5x59A: 4.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YC2_D_NCAD510_0 (NAD-DEPENDENT DEACETYLASE 2)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 5	ALA A 336 PHE A 323 ILE A 48 ASP A 54	None	1.09A	1yc2D-5x59A: undetectable	1yc2D-5x59A: 10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YDB_A_AZMA264_1 (CARBONIC ANHYDRASE II)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 11	HIS A1122 HIS A1138 VAL A1139 PHE A1001 PHE A1126	None	0.99A	1ydbA-5x59A: undetectable	1ydbA-5x59A: 12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FL5_F_RBFF204_1 (IMMUNOGLOBULIN IGG1 LAMBDA LIGHT CHAIN IMMUNOGLOBULIN IGG1 HEAVY CHAIN)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	TYR A 809 ARG A1074 VAL A 804 TYR A 932	None	1.12A	2fl5E-5x59A: undetectable 2fl5F-5x59A: undetectable	2fl5E-5x59A: 11.01 2fl5F-5x59A: 10.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X91_A_LPRA1615_2 (ANGIOTENSIN CONVERTING ENZYME)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	SER A 426 THR A 574 PHE A 446	None	0.69A	2x91A-5x59A: 2.7	2x91A-5x59A: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 7	ILE A 250 LEU A 273 TYR A 144 THR A 178	NAG A1402 ( 4.5A) None None None	1.05A	3ag2N-5x59A: undetectable 3ag2W-5x59A: undetectable	3ag2N-5x59A: 16.77 3ag2W-5x59A: 3.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CE6_D_ADND500_2 (ADENOSYLHOMOCYSTEINA SE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 5	LEU A1134 GLN A 796 THR A 797 LEU A 894	None	1.21A	3ce6D-5x59A: undetectable	3ce6D-5x59A: 16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CV9_A_VDXA501_1 (CYTOCHROME P450-SU1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 9	VAL A 853 SER A 950 ILE A 955 ILE A 795 GLY A1133	None	1.17A	3cv9A-5x59A: undetectable	3cv9A-5x59A: 15.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKX_B_1UNB201_2 (PROTEASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 11	ALA A 53 ASP A 54 ILE A 48 ILE A 337 ILE A 56	None	0.98A	3ekxB-5x59A: undetectable	3ekxB-5x59A: 6.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_E_TFPE201_1 (PROTEIN S100-A4)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 7	PHE A1001 GLY A 789 PHE A 788 PHE A 977	None	1.05A	3ko0D-5x59A: undetectable 3ko0E-5x59A: undetectable	3ko0D-5x59A: 6.21 3ko0E-5x59A: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_L_TFPL201_1 (PROTEIN S100-A4)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 7	GLY A1011 PHE A 869 PHE A 972 PHE A1126	None	1.12A	3ko0L-5x59A: 0.7 3ko0N-5x59A: 0.7	3ko0L-5x59A: 6.21 3ko0N-5x59A: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_T_TFPT201_1 (PROTEIN S100-A4)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 7	PHE A1126 GLY A1011 PHE A 869 PHE A 972	None	1.04A	3ko0R-5x59A: undetectable 3ko0T-5x59A: undetectable	3ko0R-5x59A: 6.21 3ko0T-5x59A: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LCV_B_SAMB301_0 (SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 12	TYR A 663 SER A 743 THR A 744 ALA A 671 ASP A 343	None	1.08A	3lcvB-5x59A: undetectable	3lcvB-5x59A: 11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N23_C_OBNC1_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 11	GLN A 796 ASN A1029 LEU A1033 ALA A 901 PHE A 895	None	1.41A	3n23C-5x59A: undetectable	3n23C-5x59A: 23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_B_URFB400_1 (URIDINE PHOSPHORYLASE 1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	THR A 986 GLY A 982 LEU A 980 ILE A1123	None	0.86A	3nbqB-5x59A: undetectable	3nbqB-5x59A: 13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_C_URFC400_1 (URIDINE PHOSPHORYLASE 1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	THR A 986 GLY A 982 LEU A 980 ILE A1123	None	0.80A	3nbqC-5x59A: undetectable	3nbqC-5x59A: 13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OND_A_ADNA506_2 (ADENOSYLHOMOCYSTEINA SE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	GLN A 796 THR A 797 LEU A 894	None	0.65A	3ondA-5x59A: undetectable	3ondA-5x59A: 15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OND_B_ADNB507_2 (ADENOSYLHOMOCYSTEINA SE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	GLN A 796 THR A 797 LEU A 894	None	0.66A	3ondB-5x59A: undetectable	3ondB-5x59A: 15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_E_ACTE503_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	GLN A 576 THR A 477 ASN A 475	None	0.91A	3v4tE-5x59A: undetectable	3v4tE-5x59A: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 11	TYR A 469 ASP A 444 ARG A 401 VAL A 458 ILE A 480	None	1.37A	4dz2A-5x59A: undetectable 4dz2B-5x59A: undetectable	4dz2A-5x59A: 6.77 4dz2B-5x59A: 6.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 11	TYR A 469 ASP A 444 ARG A 401 VAL A 458 ILE A 480	None	1.39A	4dz2A-5x59A: undetectable 4dz2B-5x59A: undetectable	4dz2A-5x59A: 6.77 4dz2B-5x59A: 6.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 5	TYR A1142 GLN A1119 GLY A1120 SER A1114	None	1.27A	4fu8A-5x59A: undetectable	4fu8A-5x59A: 10.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_F_CAMF502_0 (CAMPHOR 5-MONOOXYGENASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 4	TYR A 231 THR A 202 VAL A 102 ILE A 31	None	1.46A	4jx1F-5x59A: undetectable	4jx1F-5x59A: 14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4S0V_A_SUVA2001_2 (HUMAN OREXIN RECEPTOR TYPE 2 FUSION PROTEIN TO P. ABYSII GLYCOGEN SYNTHASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 5	ILE A 464 PRO A 463 TYR A 541 VAL A 530	None	1.35A	4s0vA-5x59A: undetectable	4s0vA-5x59A: 17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 6	ILE A 250 LEU A 273 TYR A 144 THR A 178	NAG A1402 ( 4.5A) None None None	1.06A	5b1aN-5x59A: undetectable 5b1aW-5x59A: undetectable	5b1aN-5x59A: 16.77 5b1aW-5x59A: 3.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BYK_A_OAQA302_0 (SULFOTRANSFERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	5 / 12	HIS A 670 ILE A 662 VAL A 659 VAL A 363 LEU A 735	None	1.07A	5bykA-5x59A: undetectable	5bykA-5x59A: 11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D4N_A_ACTA202_0 (NITROGEN REGULATORY PROTEIN P-II)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 4	VAL A 958 GLY A 959 ARG A 979 VAL A1107	None	1.11A	5d4nA-5x59A: undetectable 5d4nB-5x59A: undetectable	5d4nA-5x59A: 6.30 5d4nB-5x59A: 6.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JMN_C_FUAC1101_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	VAL A 356 HIS A 670 VAL A 661	None	0.72A	5jmnC-5x59A: undetectable	5jmnC-5x59A: 22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KF8_A_GCSA404_1 (PREDICTED ACETYLTRANSFERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	ARG A 141 GLU A 249 GLY A 121 TRP A 310	None	0.78A	5kf8A-5x59A: undetectable	5kf8A-5x59A: 13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_A_SAMA301_1 (METHYLTRANSFERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 4	SER A1034 THR A 899 ASP A 896 ASP A 902	None	1.49A	5vimA-5x59A: undetectable	5vimA-5x59A: 11.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_B_SAMB301_1 (METHYLTRANSFERASE)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 4	SER A1034 THR A 899 ASP A 896 ASP A 902	None	1.48A	5vimB-5x59A: undetectable	5vimB-5x59A: 11.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VYH_A_FOLA409_0 (S PROTEIN)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	10 / 10	TRP A 44 PRO A 45 ARG A 46 PRO A 47 HIS A 81 ALA A 123 GLY A 128 THR A 129 ILE A 140 ALA A 312	None	0.42A	5vyhA-5x59A: 53.5	5vyhA-5x59A: 42.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_B_8LXB501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 8	HIS A 298 PHE A 228 PHE A 183 LEU A 187	None	1.11A	5y2tB-5x59A: undetectable	5y2tB-5x59A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YW0_A_ACTA412_0 (UNCHARACTERIZED PROTEIN KDOO)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	LYS A 698 ASN A 719 SER A 684	None	1.18A	5yw0A-5x59A: undetectable	5yw0A-5x59A: 12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A7P_A_9SCA601_1 (SERUM ALBUMIN)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	4 / 5	ASN A 220 VAL A 21 LEU A 234 SER A 227	None NAG A1409 (-3.3A) None None	1.31A	6a7pA-5x59A: 4.8	6a7pA-5x59A: 17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GB9_A_ACTA508_0 (MOLYBDOPTERIN BIOSYNTHESIS PROTEIN CNX1)	5x59	S PROTEIN (Middle East respiratory syndrome-related coronavirus)	3 / 3	VAL A 934 ALA A 926 GLN A 800	None	0.69A	6gb9A-5x59A: undetectable	6gb9A-5x59A: 16.41

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UYU_A_CAMA1416_0","CYTOCHROME P450-CAM","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"PHE A1012;THR A 791;VAL A1128;VAL A1022","None","1.19A","1uyuA-5x59A:undetectable","1uyuA-5x59A:15.18"],["1WRK_A_TFPA204_1","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"PHE A 116;LEU A 284;PHE A 112;PHE A 183;LEU A 265","None","1.26A","1wrkA-5x59A:undetectable;1wrkB-5x59A:undetectable","1wrkA-5x59A:4.74;1wrkB-5x59A:4.74"],["1YC2_D_NCAD510_0","NAD-DEPENDENT DEACETYLASE 2","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ALA A 336;PHE A 323;ILE A  48;ASP A  54","None","1.09A","1yc2D-5x59A:undetectable","1yc2D-5x59A:10.78"],["1YDB_A_AZMA264_1","CARBONIC ANHYDRASE II","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"HIS A1122;HIS A1138;VAL A1139;PHE A1001;PHE A1126","None","0.99A","1ydbA-5x59A:undetectable","1ydbA-5x59A:12.18"],["2FL5_F_RBFF204_1","IMMUNOGLOBULIN IGG1 LAMBDA LIGHT CHAIN;IMMUNOGLOBULIN IGG1 HEAVY CHAIN","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"TYR A 809;ARG A1074;VAL A 804;TYR A 932","None","1.12A","2fl5E-5x59A:undetectable;2fl5F-5x59A:undetectable","2fl5E-5x59A:11.01;2fl5F-5x59A:10.73"],["2X91_A_LPRA1615_2","ANGIOTENSIN CONVERTING ENZYME","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"SER A 426;THR A 574;PHE A 446","None","0.69A","2x91A-5x59A:2.7","2x91A-5x59A:18.24"],["3AG2_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ILE A 250;LEU A 273;TYR A 144;THR A 178","NAG A1402 ( 4.5A);None;None;None","1.05A","3ag2N-5x59A:undetectable;3ag2W-5x59A:undetectable","3ag2N-5x59A:16.77;3ag2W-5x59A:3.92"],["3CE6_D_ADND500_2","ADENOSYLHOMOCYSTEINASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"LEU A1134;GLN A 796;THR A 797;LEU A 894","None","1.21A","3ce6D-5x59A:undetectable","3ce6D-5x59A:16.55"],["3CV9_A_VDXA501_1","CYTOCHROME P450-SU1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"VAL A 853;SER A 950;ILE A 955;ILE A 795;GLY A1133","None","1.17A","3cv9A-5x59A:undetectable","3cv9A-5x59A:15.10"],["3EKX_B_1UNB201_2","PROTEASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"ALA A  53;ASP A  54;ILE A  48;ILE A 337;ILE A  56","None","0.98A","3ekxB-5x59A:undetectable","3ekxB-5x59A:6.22"],["3KO0_E_TFPE201_1","PROTEIN S100-A4;PROTEIN S100-A4","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"PHE A1001;GLY A 789;PHE A 788;PHE A 977","None","1.05A","3ko0D-5x59A:undetectable;3ko0E-5x59A:undetectable","3ko0D-5x59A:6.21;3ko0E-5x59A:6.21"],["3KO0_L_TFPL201_1","PROTEIN S100-A4;PROTEIN S100-A4","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"GLY A1011;PHE A 869;PHE A 972;PHE A1126","None","1.12A","3ko0L-5x59A:0.7;3ko0N-5x59A:0.7","3ko0L-5x59A:6.21;3ko0N-5x59A:6.21"],["3KO0_T_TFPT201_1","PROTEIN S100-A4;PROTEIN S100-A4","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"PHE A1126;GLY A1011;PHE A 869;PHE A 972","None","1.04A","3ko0R-5x59A:undetectable;3ko0T-5x59A:undetectable","3ko0R-5x59A:6.21;3ko0T-5x59A:6.21"],["3LCV_B_SAMB301_0","SISOMICIN-GENTAMICIN RESISTANCE METHYLASE SGM","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"TYR A 663;SER A 743;THR A 744;ALA A 671;ASP A 343","None","1.08A","3lcvB-5x59A:undetectable","3lcvB-5x59A:11.92"],["3N23_C_OBNC1_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"GLN A 796;ASN A1029;LEU A1033;ALA A 901;PHE A 895","None","1.41A","3n23C-5x59A:undetectable","3n23C-5x59A:23.18"],["3NBQ_B_URFB400_1","URIDINE PHOSPHORYLASE 1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"THR A 986;GLY A 982;LEU A 980;ILE A1123","None","0.86A","3nbqB-5x59A:undetectable","3nbqB-5x59A:13.73"],["3NBQ_C_URFC400_1","URIDINE PHOSPHORYLASE 1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"THR A 986;GLY A 982;LEU A 980;ILE A1123","None","0.80A","3nbqC-5x59A:undetectable","3nbqC-5x59A:13.73"],["3OND_A_ADNA506_2","ADENOSYLHOMOCYSTEINASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"GLN A 796;THR A 797;LEU A 894","None","0.65A","3ondA-5x59A:undetectable","3ondA-5x59A:15.40"],["3OND_B_ADNB507_2","ADENOSYLHOMOCYSTEINASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"GLN A 796;THR A 797;LEU A 894","None","0.66A","3ondB-5x59A:undetectable","3ondB-5x59A:15.40"],["3V4T_E_ACTE503_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"GLN A 576;THR A 477;ASN A 475","None","0.91A","3v4tE-5x59A:undetectable","3v4tE-5x59A:14.68"],["4DZ2_A_FK5A200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"TYR A 469;ASP A 444;ARG A 401;VAL A 458;ILE A 480","None","1.37A","4dz2A-5x59A:undetectable;4dz2B-5x59A:undetectable","4dz2A-5x59A:6.77;4dz2B-5x59A:6.77"],["4DZ2_B_FK5B200_1","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"TYR A 469;ASP A 444;ARG A 401;VAL A 458;ILE A 480","None","1.39A","4dz2A-5x59A:undetectable;4dz2B-5x59A:undetectable","4dz2A-5x59A:6.77;4dz2B-5x59A:6.77"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"TYR A1142;GLN A1119;GLY A1120;SER A1114","None","1.27A","4fu8A-5x59A:undetectable","4fu8A-5x59A:10.57"],["4JX1_F_CAMF502_0","CAMPHOR 5-MONOOXYGENASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"TYR A 231;THR A 202;VAL A 102;ILE A  31","None","1.46A","4jx1F-5x59A:undetectable","4jx1F-5x59A:14.65"],["4S0V_A_SUVA2001_2","HUMAN OREXIN RECEPTOR TYPE 2 FUSION PROTEIN TO P. ABYSII GLYCOGEN SYNTHASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ILE A 464;PRO A 463;TYR A 541;VAL A 530","None","1.35A","4s0vA-5x59A:undetectable","4s0vA-5x59A:17.56"],["5B1A_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ILE A 250;LEU A 273;TYR A 144;THR A 178","NAG A1402 ( 4.5A);None;None;None","1.06A","5b1aN-5x59A:undetectable;5b1aW-5x59A:undetectable","5b1aN-5x59A:16.77;5b1aW-5x59A:3.92"],["5BYK_A_OAQA302_0","SULFOTRANSFERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",5,"HIS A 670;ILE A 662;VAL A 659;VAL A 363;LEU A 735","None","1.07A","5bykA-5x59A:undetectable","5bykA-5x59A:11.70"],["5D4N_A_ACTA202_0","NITROGEN REGULATORY PROTEIN P-II","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"VAL A 958;GLY A 959;ARG A 979;VAL A1107","None","1.11A","5d4nA-5x59A:undetectable;5d4nB-5x59A:undetectable","5d4nA-5x59A:6.30;5d4nB-5x59A:6.30"],["5JMN_C_FUAC1101_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"VAL A 356;HIS A 670;VAL A 661","None","0.72A","5jmnC-5x59A:undetectable","5jmnC-5x59A:22.56"],["5KF8_A_GCSA404_1","PREDICTED ACETYLTRANSFERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ARG A 141;GLU A 249;GLY A 121;TRP A 310","None","0.78A","5kf8A-5x59A:undetectable","5kf8A-5x59A:13.82"],["5VIM_A_SAMA301_1","METHYLTRANSFERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"SER A1034;THR A 899;ASP A 896;ASP A 902","None","1.49A","5vimA-5x59A:undetectable","5vimA-5x59A:11.43"],["5VIM_B_SAMB301_1","METHYLTRANSFERASE","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"SER A1034;THR A 899;ASP A 896;ASP A 902","None","1.48A","5vimB-5x59A:undetectable","5vimB-5x59A:11.43"],["5VYH_A_FOLA409_0","S PROTEIN","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",10,"TRP A  44;PRO A  45;ARG A  46;PRO A  47;HIS A  81;ALA A 123;GLY A 128;THR A 129;ILE A 140;ALA A 312","None","0.42A","5vyhA-5x59A:53.5","5vyhA-5x59A:42.98"],["5Y2T_B_8LXB501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"HIS A 298;PHE A 228;PHE A 183;LEU A 187","None","1.11A","5y2tB-5x59A:undetectable","5y2tB-5x59A:undetectable"],["5YW0_A_ACTA412_0","UNCHARACTERIZED PROTEIN KDOO","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"LYS A 698;ASN A 719;SER A 684","None","1.18A","5yw0A-5x59A:undetectable","5yw0A-5x59A:12.83"],["6A7P_A_9SCA601_1","SERUM ALBUMIN","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",4,"ASN A 220;VAL A  21;LEU A 234;SER A 227","None;NAG A1409 (-3.3A);None;None","1.31A","6a7pA-5x59A:4.8","6a7pA-5x59A:17.89"],["6GB9_A_ACTA508_0","MOLYBDOPTERIN BIOSYNTHESIS PROTEIN CNX1","5x59","S PROTEIN","Middle East respiratory syndrome-related coronavirus",3,"VAL A 934;ALA A 926;GLN A 800","None","0.69A","6gb9A-5x59A:undetectable","6gb9A-5x59A:16.41"]]